Argenx Se (ARGX) Accumulated Expenses (2015 - 2023)

Argenx Se (ARGX) posted Accumulated Expenses of $95.1 million for Q4 2023, up 12.77% on a QoQ basis from $84.3 million in Q4 2022, and up 12.77% year-over-year from $84.3 million in Q4 2022.

Argenx Se (ARGX) Accumulated Expenses (2015 - 2023) Analysis & Trends

Argenx Se's Accumulated Expenses history runs 8 years deep, the most recent figure standing at $95.1 million for Q4 2023.

  • Quarterly Accumulated Expenses rose 12.77% year-over-year to $95.1 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $95.1 million (up 12.77% YoY) and the FY2023 annual result came in at $95.1 million, up 12.77% from the prior year.
  • Accumulated Expenses was $95.1 million for Q4 2023 at Argenx Se, up from $84.3 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $95.1 million in Q4 2023 and bottomed at $30.2 million in Q4 2019.
  • A 5-year average of $72.4 million and a median of $83.7 million in 2021 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2020 — Accumulated Expenses surged 128.13% — and 2022, when it gained 0.72%.
  • Argenx Se's Accumulated Expenses stood at $30.2 million in 2019, then jumped by 128.13% to $68.9 million in 2020, then increased by 21.59% to $83.7 million in 2021, then grew by 0.72% to $84.3 million in 2022, then increased by 12.77% to $95.1 million in 2023.
  • Business Quant data shows ARGX's Accumulated Expenses at $95.1 million in Q4 2023, $84.3 million in Q4 2022, and $83.7 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 95.10 Mn
Dec 31, 2022 84.34 Mn
Dec 31, 2021 83.74 Mn
Dec 31, 2020 68.87 Mn
Dec 31, 2019 30.19 Mn
Dec 31, 2017 8.06 Mn
Dec 31, 2016 2.55 Mn
Dec 31, 2015 1.55 Mn